Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease - PubMed

Affiliations

• PMID: 28214524
• DOI: 10.1053/j.gastro.2017.01.055

Free article

Review

Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease

Oscar Chávez-Talavera et al. Gastroenterology. 2017 May.

Free article

Abstract

Bile acids are signaling molecules that coordinately regulate metabolism and inflammation via the nuclear farnesoid X receptor (FXR) and the Takeda G protein-coupled receptor 5 (TGR5). These receptors activate transcriptional networks and signaling cascades controlling the expression and activity of genes involved in bile acid, lipid and carbohydrate metabolism, energy expenditure, and inflammation by acting predominantly in enterohepatic tissues, but also in peripheral organs. In this review, we discuss the most recent findings on the inter-organ signaling and interplay with the gut microbiota of bile acids and their receptors in meta-inflammation, with a focus on their pathophysiologic roles in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic steatohepatitis, and their potential therapeutic applications.

Keywords: Bile Acids; FXR; Meta-Inflammation; TGR5.

Similar articles

• Role of Bile Acids in Metabolic Control.

  Molinaro A, Wahlström A, Marschall HU. Molinaro A, et al. Trends Endocrinol Metab. 2018 Jan;29(1):31-41. doi: 10.1016/j.tem.2017.11.002. Epub 2017 Nov 28. Trends Endocrinol Metab. 2018. PMID: 29195686 Review.

• Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.

  Pathak P, Liu H, Boehme S, Xie C, Krausz KW, Gonzalez F, Chiang JYL. Pathak P, et al. J Biol Chem. 2017 Jun 30;292(26):11055-11069. doi: 10.1074/jbc.M117.784322. Epub 2017 May 6. J Biol Chem. 2017. PMID: 28478385 Free PMC article.

• The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

  Chow MD, Lee YH, Guo GL. Chow MD, et al. Mol Aspects Med. 2017 Aug;56:34-44. doi: 10.1016/j.mam.2017.04.004. Epub 2017 May 5. Mol Aspects Med. 2017. PMID: 28442273 Free PMC article. Review.

• Bile acids in glucose metabolism in health and disease.

  Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E. Shapiro H, et al. J Exp Med. 2018 Feb 5;215(2):383-396. doi: 10.1084/jem.20171965. Epub 2018 Jan 16. J Exp Med. 2018. PMID: 29339445 Free PMC article. Review.

• Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.

  Chiang JYL, Ferrell JM. Chiang JYL, et al. Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G554-G573. doi: 10.1152/ajpgi.00223.2019. Epub 2020 Jan 27. Am J Physiol Gastrointest Liver Physiol. 2020. PMID: 31984784 Free PMC article. Review.

Cited by

• The mechanism of bile acid metabolism regulating lipid metabolism and inflammatory response in T2DM through the gut-liver axis.

  Wang Y, Lv B, Liu N, Tao S, Dou J, Li J, Deng R, Yang X, Jiang G. Wang Y, et al. Heliyon. 2024 Aug 12;10(16):e35421. doi: 10.1016/j.heliyon.2024.e35421. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39229512 Free PMC article.

• Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling.

  Di Ciaula A, Bonfrate L, Baj J, Khalil M, Garruti G, Stellaard F, Wang HH, Wang DQ, Portincasa P. Di Ciaula A, et al. Nutrients. 2022 Nov 22;14(23):4950. doi: 10.3390/nu14234950. Nutrients. 2022. PMID: 36500979 Free PMC article. Review.

• Plasma concentration of trimethylamine-N-oxide and risk of gestational diabetes mellitus.

  Li P, Zhong C, Li S, Sun T, Huang H, Chen X, Zhu Y, Hu X, Peng X, Zhang X, Bao W, Shan Z, Cheng J, Hu FB, Yang N, Liu L. Li P, et al. Am J Clin Nutr. 2018 Sep 1;108(3):603-610. doi: 10.1093/ajcn/nqy116. Am J Clin Nutr. 2018. PMID: 30535087 Free PMC article.

• A Review of Bile Acid Metabolism and Signaling in Cognitive Dysfunction-Related Diseases.

  Weng ZB, Chen YR, Lv JT, Wang MX, Chen ZY, Zhou W, Shen XC, Zhan LB, Wang F. Weng ZB, et al. Oxid Med Cell Longev. 2022 Mar 11;2022:4289383. doi: 10.1155/2022/4289383. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35308170 Free PMC article. Retracted. Review.

• Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?

  Xie C, Halegoua-DeMarzio D. Xie C, et al. Nutrients. 2019 Nov 19;11(11):2837. doi: 10.3390/nu11112837. Nutrients. 2019. PMID: 31752378 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • HAL archives ouvertes

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information